首页/数据集/Crystal structure of HIV-1 RRE SLII A31CG39C mutant in complex with Fab BL3-6

Crystal structure of HIV-1 RRE SLII A31CG39C mutant in complex with Fab BL3-6

NIAID Data Ecosystem2026-05-02 收录

病毒RNA结构

药物开发

数据链接：

https://www.rcsb.org/structure/9E7E 数据链接链接失效反馈

官方服务：

资源简介：

Crystal structure of HIV-1 RRE SLII A31CG39C mutant in complex with Fab BL3-6

应用场景：

创建时间：

2025-05-28

相关数据集

concizumab

药物开发

血友病治疗

Concizumab (mAb 2021) is a high-affinity, humanized, monoclonal IgG4 antibody (mAb) developed by Novo Nordisk A/S. It was directed against the Kunitz-2 domain of human tissue factor (TF) pathway inhib

DataONE2023-06-18 更新300

Computational and Structure-Based Development of High Potent Cell-Active Covalent Inhibitor Targeting the Peptidyl-Prolyl Isomerase NIMA-Interacting‑1 (Pin1)

癌症治疗

药物开发

The unique proline isomerase peptidyl-prolyl isomerase NIMA-interacting-1 (Pin1) is reported to activate numerous cancer-driving pathways simultaneously, and aberrant Pin1 activation is present in man

NIAID Data Ecosystem70

GNYA tetranucleotide loops found in poliovirus oriL by in vivo SELEX (un)expectedly form a YNMG-like structure

病毒RNA结构

脊髓灰质炎病毒基因研究

GNYA tetranucleotide loops found in poliovirus oriL by in vivo SELEX (un)expectedly form a YNMG-like structure Descriptor: Poliovirus 5'NTR cloverleaf stem loop D mutant Authors: Melchers, W.J.G, Zoll

Protein Data Bank Japan2024-05-22 更新50

Replication data for: Regulatory Incentives for Innovation: the FDA's Breakthrough Therapy Designation

监管激励

药物开发

Replication data for: Regulatory Incentives for Innovation: the FDA's Breakthrough Therapy Designation

DataONE2024-01-29 更新80

Cathepsin L (CTSL) - BioCentury Target Profiles - BCIQ

生物制药

药物开发

Cathepsin L (CTSL) - BioCentury Target Profiles for the biopharma industry

profiles.biocentury.com60